Table 1.
Personalized Nanomedicines |
---|
Nanometric scale dimensions |
Tunability/versatility |
Use of labile compounds (e.g., siRNA) |
Active principles: encapsulation and protection |
Modification of actives pharmacokinetics |
Specific organ targeting moieties |
Arrival to specific cellular compartments |
Adaptation to the requirements of a cohort of patients |
Adaptation of therapy patterns to each patient (e.g., dosage, frequency, etc.) |